BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000470 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
30,000
Total Value
$838,955.63
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 10,000 | $16.75 | $167,500.00 | 21,589 | Direct | โ | View Details | |
Director | Common Stock | โ | May 15, 2026 | Sale | 6,200 | $66.69 | $413,464.36 | 15,389 | Direct | โ | View Details | |
Director | Common Stock | โ | May 15, 2026 | Sale | 2,088 | $67.53 | $141,003.06 | 13,301 | Direct | โ | View Details | |
Director | Common Stock | โ | May 15, 2026 | Sale | 1,512 | $68.23 | $103,164.21 | 11,789 | Direct | โ | View Details | |
Director | Common Stock | โ | May 15, 2026 | Sale | 200 | $69.12 | $13,824.00 | 11,589 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | May 15, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 21,501 | Direct | โ | View Details |